About IntelliSyn
IntelliSyn is a company based in Montreal (Canada) founded in 2011 was acquired by X-Chem in January 2021. IntelliSyn operates in a competitive market with competitors including Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IntelliSyn
Detailed funding history for IntelliSyn
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IntelliSyn
IntelliSyn has secured backing from 1 investor. Prominent investors backing the company include X-Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule drug discovery platform is provided to researchers.
|
Locked | Locked | Locked |
Investor details for IntelliSyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntelliSyn
Investment portfolio details for IntelliSyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IntelliSyn
Detailed financials for IntelliSyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intellisyn Comparisons
Peer comparison for IntelliSyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IntelliSyn
IntelliSyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Integrated chemistry service provider
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Drug discovery services are manufactured by Anagenex in San Francisco.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
Detailed competitors of IntelliSyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intellisyn
Complete news archive for IntelliSyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntelliSyn
IntelliSyn was founded in 2011.
IntelliSyn is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
IntelliSyn was founded in 2011 in Montreal, Canada, as a contract research organization in the pharmaceutical sector. Services encompass synthetic chemistry, computational modeling, analytical techniques, in vitro assays, and in vivo studies to support drug development. Operations are centered on collaborative research for biotech and pharmaceutical clients, with a focus on efficient discovery processes.
IntelliSyn's top competitors include Generate Biomedicines, Sai Life Sciences and Plexium.
IntelliSyn has 1 investor. Key investors include X-Chem.